Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Rare cancers of childhood (NCI PDQ umbrella), Rare cancers, Hereditary cancer syndromes, Cabozantinib and the tags rare, endocrine.
Shares Multiple endocrine neoplasia syndromes (MEN1, MEN2, MEN4), Rare cancers, Hereditary cancer syndromes, Germline (hereditary) testing and the tags rare, endocrine.
Shares Multiple endocrine neoplasia syndromes (MEN1, MEN2, MEN4), Peptide receptor radionuclide therapy (PRRT), Rare cancers, Somatostatin receptor 2 and the tags rare, endocrine.
Shares Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors, VHL, 131I-MIBG (iobenguane I-131) therapy, MIBG imaging and 131I-MIBG therapy and the tag endocrine.
Shares Multiple endocrine neoplasia syndromes (MEN1, MEN2, MEN4), Rare cancers of childhood (NCI PDQ umbrella), RET, Cabozantinib and the tag endocrine.
Shares Sunitinib, VEGF / VEGFR, Novartis, Rare and paediatric cancers without markets and the tag rare.
Shares Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL, Somatostatin receptor PET (68Ga/64Cu-DOTATATE), HIF-2α, Peptide receptor radionuclide therapy (PRRT) and the tag endocrine.
Shares Adrenalectomy, Metastatic pheochromocytoma and paraganglioma, Cabozantinib, VEGF / VEGFR and the tag endocrine.
The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.